Derivation of human decidua-like cells from amnion and menstrual blood

Scientific Reports

Volumn 3, Issue , 2014, Pages

  Sugawara, Kana ^a,b   Hamatani, Toshio ^a   Yamada, Mitsutoshi ^a   Ogawa, Seiji ^a   Kamijo, Shintaro ^a   Kuji, Naoaki ^a   Akutsu, Hidenori ^b   Miyado, Kenji ^b   Yoshimura, Yasunori ^a   Umezawa, Akihiro ^b  

^a KEIO UNIVERSITY   (Japan)

^b NATIONAL RESEARCH INSTITUTE FOR CHILD HEALTH AND DEVELOPMENT   (Japan)

Author keywords

[No Author keywords available]

Indexed keywords

8 BROMO CYCLIC AMP; CD9 ANTIGEN; CD9 PROTEIN, HUMAN; ESTROGEN; KERATIN; MEMBRANE METALLOENDOPEPTIDASE; MEMBRANE PROTEIN; PROGESTERONE; PROLACTIN; SOMATOMEDIN BINDING PROTEIN 1; VIMENTIN;

AMNION; ARTICLE; BIOSYNTHESIS; BLOOD; BONE MARROW CELL; CELL DIFFERENTIATION; CELL LINE; CYTOLOGY; DECIDUA; ENDOMETRIUM; FEMALE; HELA CELL LINE; HUMAN; MENSTRUATION; MESENCHYMAL STROMA CELL; METABOLISM;

8-BROMO CYCLIC ADENOSINE MONOPHOSPHATE; AMNION; ANTIGENS, CD9; BONE MARROW CELLS; CELL DIFFERENTIATION; CELL LINE; DECIDUA; ENDOMETRIUM; ESTROGENS; FEMALE; HELA CELLS; HUMANS; INSULIN-LIKE GROWTH FACTOR BINDING PROTEIN 1; KERATINS; MEMBRANE PROTEINS; MENSTRUATION; MESENCHYMAL STROMAL CELLS; NEPRILYSIN; PROGESTERONE; PROLACTIN; VIMENTIN;

EID: 84910126449     PISSN: None     EISSN: 20452322     Source Type: Journal    
DOI: 10.1038/srep04599     Document Type: Article

References (50)

1. Lee, T. H. et al. Embryo quality ismore important for younger women whereas age is more important for older women with regard to in vitro fertilization outcome and multiple pregnancy. Fertil Steril 86, 64-69 (2006).
2. Navot, D. et al. Poor oocyte quality rather than implantation failure as a cause of age-related decline in female fertility. Lancet 337, 1375-1377 (1991).
3. Amir, W. et al. Predicting factors for endometrial thickness during treatment with assisted reproductive technology. Fertil Steril 87, 799-804 (2007).
4. Senturk, L. M. & Erel, C. T. Thin endometrium in assisted reproductive technology. Curr Opin Obstet Gynecol 20, 221-228 (2008).
5. Sallam, H. N. Embryo transfer: factors involved in optimizing the success. Curr Opin Obstet Gynecol 17, 289-298 (2005).
6. Check, J. H. et al. Neither sildenafil nor vaginal estradiol improves endometrial thickness in women with thin endometria after taking oral estradiol in graduating dosages. Clin Exp Obstet Gynecol 31, 99-102 (2004).
7. Landgren, B. M., Johannisson, E., Stavreus-Evers, A., Hamberger, L. & Eriksson, H. A new method to study the process of implantation of a human blastocyst in vitro. Fertil Steril 65, 1067-1070 (1996).
8. Eyheremendy, V. et al. Beneficial effect of autologous endometrial cell coculture in patients with repeated implantation failure. Fertil Steril 93, 769-773 (2010).
9. Lee, E. J. et al. Spherical bullet formation via E-cadherin promotes therapeutic potency of mesenchymal stem cells derived from human umbilical cord blood for myocardial infarction. Mol Ther 20, 1424-1433 (2012).
10. Qiu, Y., Marquez-Curtis, L. & Janowska-Wieczorek, A. Mesenchymal stromal cells derived from umbilical cord blood migrate in response to complement C1q. Cytotherapy 14, 285-295 (2012).
11. Moorefield, E. C. et al. Cloned, CD117 selected human amniotic fluid stem cells are capable of modulating the immune response. PLoS One 6, e26535 (2011).
12. Gargett, C. E. & Healy, D. L. Generating receptive endometrium in Asherman's syndrome. J Hum Reprod Sci 4, 49-52 (2011).
13. Pittenger, M. F. et al. Multilineage Potential of Adult Human Mesenchymal Stem Cells. Science 284, 143-147 (1999).
14. Miki, T., Lehmann, T., Cai, H., Stolz, D. B. & Strom, S. C. Stem cell characteristics of amniotic epithelial cells. Stem Cells 23, 1549-1559 (2005).
15. Santos, T. M. et al. Expression of pancreatic endocrine markers by mesenchymal stem cells from human umbilical cord vein. Transplant Proc 42, 563-565 (2010).
16. Lee, K. D. et al. In vitro hepatic differentiation of human mesenchymal stem cells. Hepatology 40, 1275-1284 (2004).
17. Pournasr, B. et al. In vitro differentiation of human bone marrow mesenchymal stem cells into hepatocyte-like cells. Arc Iran Med 14, 244-249 (2011).
18. Dezawa, M. et al. Specific induction of neuronal cells from bone marrow stromal cells and application for autologous transplantation. J Clin Invest 113, 1701-1710 (2004).
19. Aghajanova, L., Horcajadas, J. A., Esteban, F. J. & Giudice, L. C. The bone marrowderived human mesenchymal stem cell: potential progenitor of the endometrial stromal fibroblast. Biol Reprod 82, 1076-1087 (2010).
20. Diaz-Prado, S. et al. Human amniotic membrane as an alternative source of stem cells for regenerative medicine. Differentiation 81, 162-171 (2011).
21. Cui, C. H. et al. Menstrual blood-derived cells confer human dystrophin expression in the murine model of Duchenne muscular dystrophy via cell fusion and myogenic transdifferentiation. Mol Biol Cell 18, 1586-1594 (2007).
22. Kawamichi, Y. et al. Cells of extraembryonic mesodermal origin confer human dystrophininthe mdx modelof Duchenne muscular dystrophy. J Cell Physiol 223, 695-702 (2010).
23. Tsuji, H. et al. Xenografted human amniotic membrane-derived mesenchymal stem cells are immunologically tolerated and transdifferentiated into cardiomyocytes. Circ Res 106, 1613-1623 (2010).
24. Sakai, N. et al. Involvement of histone acetylation in ovarian steroid-induced decidualization of human endometrial stromal cells. J Biol Chem 278, 16675-16682 (2003).
25. Tamura, I. et al. Induction of IGFBP-1 expression by cAMP is associated with histone acetylation status of the promoter region in human endometrial stromal cells. Endocrinology 153, 5612-5621 (2012).
26. Malumbres, M. & Pellicer, A. RAS pathways to cell cycle control and cell transformation. Front Biosci 3, d887-912 (1998).
27. Campioni, D. et al. A decreased positivity for CD90 on human mesenchymal stromal cells (MSCs) is associated with a loss of immunosuppressive activity by MSCs. Cytometry B Clin Cytom 76, 225-230 (2009).
28. Gaebel, R. et al. Cell origin of human mesenchymal stem cells determines a different healing performance in cardiac regeneration. PLoS One 6, e15652 (2011).
29. Rosu-Myles, M., Fair, J., Pearce, N. & Mehic, J. Non-multipotent stroma inhibit the proliferation and differentiation of mesenchymal stromal cells in vitro. Cytotherapy 12, 818-830 (2010).
30. Jin, H. J. et al. Down-regulation of CD105 is associated with multi-lineage differentiation in human umbilical cord blood-derived mesenchymal stem cells. Biochem Biophys Res Commun 381, 676-681 (2009).
31. Bratincsák, A. et al. CD45-positive blood cells give rise to uterine epithelial cells in mice. Stem Cells 25, 2820-2826 (2007).
32. Cui, C. H. et al. Dystrophin conferral using human endothelium expressingHLA-E in the non-immunosuppressive murine model of Duchenne muscular dystrophy. Hum Mol Genet 20, 235-244 (2011).
33. Selmani, Z. et al. HLA-G is a crucial immunosuppressive molecule secreted by adult human mesenchymal stem cells. Transplantation 87, S62-S66 (2009).
34. Rouas-Freiss, N., Goncalves, R. M., Menier, C., Dausset, J. & Carosella, E. D. Direct evidence to support the role of HLA-G in protecting the fetus from maternal uterine natural killer cytolysis. Proc Natl Acad Sci USA 94, 11520-11525 (1997).
35. Fernandez, N. et al. A critical review of the role of the major histocompatibility complex in fertilization, preimplantation development and feto-maternal interactions. Hum Reprod Update 5, 234-248 (1999).
36. Pazmany, L. et al. Protection from natural killer cell-mediated lysis by HLA-G expression on target cells. Science 274, 792-795 (1996).
37. Selmani, Z. et al. Human leukocyte antigen-G5 secretion by human mesenchymal stem cells is required to suppress T lymphocyte and natural killer function and to induce CD4 1 CD25highFOXP31 regulatory T cells. Stem Cells 26, 212-222 (2008).
38. Hutter, H. et al. Expression of HLA class I molecules in human first trimester and term placenta trophoblast. Cell Tissue Res 286, 439-447 (1996).
39. Paietta, E. Expression of cell-surface antigens in acute promyelocytic leukaemia. Best Practice & Research Clinical Haematology 16, 369-385 (2003).
40. Gayoso, I. et al. Immunosenescence of human natural killer cells. J Innate Immun 3, 337-343 (2011).
41. Fujimoto, M. & Sato, S. B cell signaling and autoimmune diseases: CD19/CD22 loop as a B cell signaling device to regulate the balance of autoimmunity. J Dermatol Sci 46, 1-9 (2007).
42. Mafi, P., Hindocha, S., Mafi, R., Griffin, M. & Khan, W. S. Adult mesenchymal stem cells and cell surface characterization - a systematic review of the literature. The Open Orthopaedics Journal 5, 253-260 (2011).
43. Han, K. et al. Human amnion-derived mesenchymal stem cells are a potential source for uterine stem cell therapy. Cell Prolif 41, 709-725 (2008).
44. Nery, A. A. et al. Human mesenchymal stem cells: from immunophenotyping by flow cytometry to clinical applications. Cytometry Part A 83, 48-61 (2013).
45. Kasprzak, A., Surdacka, A., Tomczak, M. & Konkol, M. Role of high endothelial postcapillary venules and selected adhesion molecules in periodontal diseases: a review. J Periodontal Res 48, 1-21 (2013).
46. Elghetany, M. T. & Lacombe, F. Physiologic variations in granulocytic surface antigen expression: impact of age, gender, pregnancy, race, and stress. J Leukoc Biol 75, 157-162 (2004).
47. Crisan, M., Corselli, M., Chen, W. C. W. & Péault, B. Perivascular cells for regenerative medicine. J Cell Mol Med 16, 2851-2860 (2012).
48. Alakel, N. et al. Direct contact with mesenchymal stromal cells affects migratory behavior and gene expression profile of CD1331hematopoietic stem cells during ex vivo expansion. Exp Hematol 37, 504-513 (2009).
49. Dvorakova, J., Hruba, A., Velebny, V. & Kubala, L. Isolation and characterization of mesenchymal stem cell population entrapped in bone marrow collection sets. Cell Biol Int 32, 1116-1125 (2008).
50. Mori, T. et al. Combination of hTERT and bmi-1, E6, or E7 induces prolongation of the life span of bone marrow stromal cells from an elderly donor without affecting their neurogenic potential. Mol Cell Biol 25, 5183-5195 (2005).